| 1 |
申春梅，冷蓓铮，刘亚隽，等. 成人非典型社区获得性肺炎患者病原体感染情况分析[J]. 检验医学，2020, 35(1): 29-32.
|
| 2 |
刘 熙，李 琦. 我国成人社区获得性肺炎诊疗现状及思考[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(3): 387-389.
|
| 3 |
Kurt E, Ak R, Eke Kurt SZ, et al. Prognostic utility of CURB-65 and E-CURB-65 scoring systems in healthcare associated pneumonia patients: Short-and long-term mortality[J]. Niger J Clin Pract, 2021, 24(11): 1706-1711.
|
| 4 |
孙 振，夏 丽，余红梅. PSI评分和CURB-65评分对不同年龄分段老年社区获得性肺炎预后评估价值的研究[J]. 中华全科医学，2020, 18(3): 392-395; 392-395, 407.
|
| 5 |
Baumann P, Fuchs A, Gotta V, et al. The kinetic profiles of copeptin and mid regional proadrenomedullin(MR-MR-proADM) in pediatric lower respiratory tract infections[J]. PLoS One, 2022, 17(3): e0264305-e0264317.
|
| 6 |
Kitamura K, Sakata J, Kangawa K, et al. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin[J]. Biochem Biophys Res Commun, 1993, 194(2): 720-725.
|
| 7 |
Iring A, Jin YJ, Albarrán-Juárez J, et al. Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure[J]. J Clin Invest, 2019, 129(7): 2775-2791.
|
| 8 |
Samson WK. Proadrenomedullin-derived peptides[J]. Front Neuroendocrinol，1998, 19(2): 100-127.
|
| 9 |
Piccioni A, Saviano A, Cicchinelli S, et al. Proadrenomedullin in sepsis and septic shock: A role in the emergency department[J]. Medicina (Kaunas), 2021, 57(9): 920-926.
|
| 10 |
Fahmey SS, Mostafa H, Elhafeez NA, et al. Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis[J]. Korean J Pediatr, 2018, 61(5): 156-159.
|
| 11 |
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
|
| 12 |
Aliberti S, Cruz CSD, Amati F, et al. Community-acquired pneumonia[J]. Lancet, 2021, 398(10303): 906-919.
|
| 13 |
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America[J]. Am J Respir Crit Care Med, 2019, 200(7): e45-e67.
|
| 14 |
Torres A, Cillóniz C, Ferrer M, et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis[J]. Eur Respir J, 2015, 45(5): 1353-1363.
|
| 15 |
Charles CJ, Lainchbury JG, Nicholls MG, et al. Adrenomedullin and the renin-angiotensin-aldosterone system[J]. Regul Pept, 2003, 112(1-3): 41-49.
|
| 16 |
Ishiyama H, Tanaka T, Saito S, et al. Plasma mid-regional pro-adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke[J]. Brain Pathol, 2023, 33(2): e13110-e13121.
|
| 17 |
Meyer Sauteur PM, Berger C. Proadrenomedullin in mycoplasma pneumoniae community-acquired pneumonia in Children[J]. Clin Infect Dis, 2021, 73(7): e1769-e1771.
|
| 18 |
王 娜，李俊玉，商 娜. 肾上腺髓质中段肽联合危重症评分在脓毒症患者预后评价中的作用[J]. 中国急救医学，2022, 42(3): 204-208.
|
| 19 |
Ferrero H, Larrayoz IM, Gil-Bea FJ, et al. Adrenomedullin, a novel target for neurodegenerative diseases[J]. Mol Neurobiol, 2018, 55(12): 8799-8814.
|
| 20 |
van Lier D, Kox M, Pickkers P. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3[J]. J Intern Med, 2021, 289(6): 792-806.
|
| 21 |
Osman M, Manosuthi W, Kaewkungwal J, et al. Etiology, clinical course, and outcomes of pneumonia in the elderly: a retrospective and prospective cohort study in Thailand[J]. Am J Trop Med Hyg, 2021, 104(6): 2009-2016.
|
| 22 |
张春玲，杨远见，刘 畅，等. 血清降钙素原、肝素结合蛋白、白细胞介素-6联合序贯器官衰竭评分对重症肺炎患者预后评估的意义[J]. 实用医学杂志，2022, 38(2): 168-172.
|
| 23 |
郭沫然，张志华，张秀珑. 肾上腺髓质素与血小板相关参数对社区获得性肺炎的诊断价值[J]. 中国呼吸与危重监护杂志，2019, 18(6): 577-580.
|
| 24 |
Špinarová M, Špinar J, Špinarová L, et al. Relation between mid-regional pro-adrenomedullin in patients with chronic heart failure and the dose of diuretics in 2-year follow-up-data from FAR NHL registry[J]. Medicina, 2022, 58(10): 1477-1486.
|
| 25 |
Öner Ö，Deveci F, Telo S, et al. MR-proADM and MR-proANP levels in patients with acute pulmonary embolism[J]. J Med Biochem, 2020, 39(3): 328-335.
|
| 26 |
Horiuchi Y, Wettersten N, Patel MP, et al. Biomarkers enhance discrimination and prognosis of type 2 myocardial infarction[J]. Circulation, 2020, 142(16): 1532-1544.
|
| 27 |
Baldirà J, Ruiz-Rodríguez JC, Wilson DC, et al. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code[J]. Ann Intensive Care, 2020, 10(1): 7-17.
|
| 28 |
Liu D, Xie L, Zhao H, et al. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis[J]. BMC Infect Dis, 2016, 16(1): 232-242.
|
| 29 |
Fialek B, De Roquetaillade C, Pruc M, et al. Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients[J]. Ann Med, 2023, 55(1): 379-387.
|
| 30 |
Gregoriano C, Koch D, Kutz A, et al. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study[J]. Clin Chem Lab Med, 2021, 59(5): 995-1004.
|